Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00449501
Status:
COMPLETED
Last Update Posted:
2011-01-24
First Post:
2007-03-16
Brief Title:
A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A Two-week Randomised Double-blind Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects 18 Years With Mild to Moderate Asthma Receiving SYMBICORT pMDI 8045 μg x 2 Actuations Twice Daily or Budesonide HFA pMDI 80 μg x 2 Act Twice Daily
Status:
COMPLETED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to demonstrate whether subjects respond similarly to the Onset of Effect Questionnaire OEQ administered pre-dose versus post-dose while receiving SYMBICORT pMDI 8045 μg x 2 actuations twice daily or budesonide HFA pMDI 80 μg x 2 actuations twice daily
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None